Cynosure Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-3,180
Closed -$808K – 166
2026
Q2
$808K Buy
3,180
+976
+44% +$227K 0.12% 60
2026
Q1
$539K Buy
+2,204
New +$513K 0.07% 78
2024
Q1
– Sell
-1,580
Closed -$248K – 332
2023
Q4
$248K Buy
+1,580
New +$242K 0.04% 138
2020
Q2
– Sell
-3,313
Closed -$434K – 38
2020
Q1
$434K Sell
3,313
-585
-15% -$83K 0.31% 36
2019
Q4
$569K Hold
3,898
– – 0.3% 29
2019
Q3
$504K Sell
3,898
-1,379
-26% -$182K 0.27% 31
2019
Q2
$735K Buy
+5,277
New +$730K 0.34% 30

Other funds holding JNJ

Cynosure Group's JNJ Position: Q3 2026 in Review

Cynosure Group sold out of Johnson & Johnson (JNJ) in Q3 2026, closing a stake of 3,180 shares — an estimated $808K sold.

Cynosure Group first reported a position in JNJ in Q2 2019 and held it in 7 quarters. The position peaked at $808K in Q2 2026. 4,739 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Cynosure Group reported no remaining Johnson & Johnson position as of Q3 2026 after selling out during the quarter.
  • Cynosure Group sold 3,180 Johnson & Johnson shares in Q3 2026, an estimated $808K.
  • Cynosure Group first reported a position in Johnson & Johnson in Q2 2019 and held it in 7 quarters.
  • Cynosure Group's Johnson & Johnson position peaked at $808K in Q2 2026.
  • 4,739 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Cynosure Group's 13F filing for Q3 2026, filed 3 Nov 2026.